A Systems-level Characterization of the Differentiation of Human Embryonic Stem Cells into Mesenchymal Stem Cells*[S]
A. Billing(MACOM (United States)), Johannes Graumann(Weill Cornell Medical College in Qatar)
Cited by 17
Related Papers
Connecting genetic risk to disease end points through the human blood plasma proteome
|Nature Communications|2017|838
Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers
|Scientific Reports|2016|137
Metabolic Communication by SGLT2 Inhibition
|Circulation|2023|127